Kayli Wagner, OTR in Chula Vista, CA - Occupational Therapist

Kayli Wagner, OTR is a Occupational Therapist based in Chula Vista, California. Kayli Wagner is licensed to practice in California (license number 17138) and her current practice location is 183 3rd Ave, Chula Vista, California. She can be reached at her office (for appointments etc.) via phone at (800) 310-4696.

NPI number for Kayli Wagner is 1053852988 and her current mailing address is 11529 Lakeside Ave, Lakeside, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1053852988.

Contact Information

	Kayli Wagner, OTR
	183 3rd Ave, Chula Vista, CA 91910-1822
	(800) 310-4696
	Not Available

Healthcare Provider's Profile

Full Name	Kayli Wagner
Gender	Female
Speciality	Occupational Therapist
Location	183 3rd Ave, Chula Vista, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1053852988
Provider Enumeration Date: 03/11/2017
Last Update Date: 03/11/2017

Medical Identifiers

Medical identifiers for Kayli Wagner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053852988	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	17138 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kayli Wagner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kayli Wagner, OTR 11529 Lakeside Ave, Lakeside, CA 92040-1651 Ph: (619) 729-0538	Kayli Wagner, OTR 183 3rd Ave, Chula Vista, CA 91910-1822 Ph: (800) 310-4696

News Archive

Baucus: Comparative effectiveness will be in health reform bill

Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"

SARS-CoV-2 Lambda variant spreading rapidly in South America, report reveals

A new research paper by researchers in Peru describes a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as the Lambda variant (C.37). The Lambda variant was first reported in Lima, Peru, in December 2020, and from April 2021, nearly all the coronavirus infections in the country are caused by it.

NSAIDs significantly inhibit ovulation in women with mild musculoskeletal pain

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) show that diclofenac, naproxen and etoricoxib significantly inhibit ovulation in women with mild musculoskeletal pain. Of the women receiving NSAIDs, only 6.3 percent (diclofenac), 25 percent (naproxen) and 27.3 percent (etoricoxib) ovulated, compared with 100 percent of the control group.

House Ways and Means Health Subcommittee will make Medicare prescription drug benefit oversight priority in 2007

The House Ways and Means Subcommittee on Health will examine oversight of the Medicare prescription drug benefit among other priorities for the 110th Congress, House Ways and Means Committee Chair Charles Rangel (D-N.Y.) and ranking member Jim McCrery (R-La.) wrote in a letter sent last Wednesday to leaders of the House Oversight and Government Reform Committee and the House Administration Committee, CQ HealthBeat reports.

Geisinger, InVivo to conduct injectable biocompatible hydrogel preclinical study for PNI

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research collaboration to conduct a preclinical study using InVivo's injectable biocompatible hydrogel for the treatment of chronic pain caused by peripheral nerve compression.

Occupational Therapist in Chula Vista, CA

Beverly Dovan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1040 Tierra Del Rey Ste 107, Chula Vista, CA 91910 Phone: 619-500-5884
Brian Delposo, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3130 Bonita Rd Ste 100, Chula Vista, CA 91910 Phone: 619-585-7104 Fax: 619-585-7106
Marissa Agatha Sheppard, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1337 Blue Sage Way, Chula Vista, CA 91915 Phone: 619-398-6990 Fax: 619-754-6907
Stacie M Gomez, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2437 Fenton St, Chula Vista, CA 91914 Phone: 619-656-5176
Daphne Fernandez, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1230 Rockland Ct, Chula Vista, CA 91913 Phone: 619-370-4977
Leah Prijoles, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 Ridgeback Rd Ste 2, Chula Vista, CA 91910 Phone: 757-650-6636

Kayli Wagner, OTR - Occupational Therapist in Chula Vista, CA